On 15 October, the Committee of the European Directorate for quality of medical products (EDQM) decided to suspend the certificate of suitability R1-CEP 2009-267-Rev 01 for the pharmaceutical substance "Erythromycin" and the certificate of suitability R0-CEP 2013-342-Rev 02 for the pharmaceutical substance "Bisoprolol fumarate" produced by "Meta Eypiay HTP".Ltd.", India ("Mehta API Pvt.Ltd."; Gut No.546,571,519 & 520, Kumbhavali Village Tarapur,…